このページの翻訳は実験的なもので、現在開発中です。お待ちしております！
Shilpa Medicare マネジメント
マネジメント 基準チェック /24
Shilpa Medicare'sの CEO はVishnukanth Bhutadaで、 Aug2022年に任命され、 の在任期間は 1.83年です。 の年間総報酬は₹ 35.00Mで、 100%給与と0%のボーナス（会社の株式とオプションを含む）で構成されています。 は、会社の株式の8.87%を直接所有しており、その価値は₹ 4.15B 。経営陣と取締役会の平均在任期間はそれぞれ2.1年と2.8年です。
主要情報
Vishnukanth Bhutada
最高経営責任者
₹35.0m
報酬総額
| CEO給与比率 | 100.0% |
| CEO在任期間 | 1.8yrs |
| CEOの所有権 | 8.9% |
| 経営陣の平均在職期間 | 2.1yrs |
| 取締役会の平均在任期間 | 2.8yrs |
経営陣の近況
Recent updates
What Shilpa Medicare Limited's (NSE:SHILPAMED) 27% Share Price Gain Is Not Telling You
Apr 12
Shilpa Medicare Limited's (NSE:SHILPAMED) Shares Climb 28% But Its Business Is Yet to Catch Up
Feb 21Shilpa Medicare (NSE:SHILPAMED) Takes On Some Risk With Its Use Of Debt
Jan 02These 4 Measures Indicate That Shilpa Medicare (NSE:SHILPAMED) Is Using Debt Extensively
Jul 17Shilpa Medicare (NSE:SHILPAMED) Seems To Be Using A Lot Of Debt
Mar 17Increases to CEO Compensation Might Be Put On Hold For Now at Shilpa Medicare Limited (NSE:SHILPAMED)
Sep 22Shilpa Medicare's (NSE:SHILPAMED) Dividend Will Be ₹1.10
Sep 07Shilpa Medicare's (NSE:SHILPAMED) Dividend Will Be ₹1.10
Aug 14Here's Why Shilpa Medicare (NSE:SHILPAMED) Is Weighed Down By Its Debt Load
Jan 27Shareholders May Not Be So Generous With Shilpa Medicare Limited's (NSE:SHILPAMED) CEO Compensation And Here's Why
Sep 21Does Shilpa Medicare (NSE:SHILPAMED) Have A Healthy Balance Sheet?
Jun 17If You Like EPS Growth Then Check Out Shilpa Medicare (NSE:SHILPAMED) Before It's Too Late
May 31Shilpa Medicare Limited's (NSE:SHILPAMED) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?
Mar 07Shilpa Medicare Limited (NSE:SHILPAMED) Analysts Are Reducing Their Forecasts For Next Year
Feb 20Does Shilpa Medicare (NSE:SHILPAMED) Have A Healthy Balance Sheet?
Jan 26
Here's Why I Think Shilpa Medicare (NSE:SHILPAMED) Is An Interesting Stock
Jan 14Shilpa Medicare (NSE:SHILPAMED) Shareholders Have Enjoyed A 54% Share Price Gain
Jan 03Could The Shilpa Medicare Limited (NSE:SHILPAMED) Ownership Structure Tell Us Something Useful?
Dec 22Is There More To The Story Than Shilpa Medicare's (NSE:SHILPAMED) Earnings Growth?
Dec 11How Much Are Shilpa Medicare Limited (NSE:SHILPAMED) Insiders Taking Off The Table?
Nov 30How Is Shilpa Medicare's (NSE:SHILPAMED) CEO Compensated?
Nov 16Earnings Release: Here's Why Analysts Cut Their Shilpa Medicare Limited (NSE:SHILPAMED) Price Target To ₹611
Nov 04CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | ₹319m |
| Dec 31 2023 | n/a | n/a | -₹7m |
| Sep 30 2023 | n/a | n/a | -₹119m |
| Jun 30 2023 | n/a | n/a | -₹321m |
| Mar 31 2023 | ₹35m | ₹35m | -₹325m |
| Dec 31 2022 | n/a | n/a | ₹51m |
| Sep 30 2022 | n/a | n/a | ₹213m |
| Jun 30 2022 | n/a | n/a | ₹599m |
| Mar 31 2022 | ₹97m | ₹16m | ₹607m |
| Dec 31 2021 | n/a | n/a | ₹395m |
| Sep 30 2021 | n/a | n/a | ₹376m |
| Jun 30 2021 | n/a | n/a | ₹631m |
| Mar 31 2021 | ₹97m | ₹16m | ₹1b |
| Dec 31 2020 | n/a | n/a | ₹2b |
| Sep 30 2020 | n/a | n/a | ₹2b |
| Jun 30 2020 | n/a | n/a | ₹2b |
| Mar 31 2020 | ₹99m | ₹10m | ₹2b |
| Dec 31 2019 | n/a | n/a | ₹1b |
| Sep 30 2019 | n/a | n/a | ₹1b |
| Jun 30 2019 | n/a | n/a | ₹944m |
| Mar 31 2019 | ₹75m | ₹10m | ₹1b |
| Dec 31 2018 | n/a | n/a | ₹1b |
| Sep 30 2018 | n/a | n/a | ₹1b |
| Jun 30 2018 | n/a | n/a | ₹1b |
| Mar 31 2018 | ₹81m | ₹16m | ₹1b |
報酬と市場: Vishnukanthの 総報酬 ($USD 419.41K ) は、 Indian市場 ($USD 264.21K ) の同規模の企業の平均を上回っています。
報酬と収益: Vishnukanthの報酬は、過去 1 年間の会社の業績と一致しています。
CEO（最高経営責任者
Vishnukanth Bhutada (62 yo)
1.8yrs
在職期間
₹35,000,000
報酬
Mr. Vishnukanth Chaturbhuj Bhutada, B. Pharm. serves as the Managing Director of Shilpa Medicare Limited since August 11, 2022 . Mr. Bhutada joined Shilpa Medicare Limited in November 1987.He serves as th...
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| MD & Director | 1.8yrs | ₹35.00m | 8.87% ₹ 4.4b | |
| Chief Financial Officer | 3.1yrs | ₹13.20m | 0.0023% ₹ 1.1m | |
| VP of Projects & Operations and Whole-time Director | no data | ₹14.50m | データなし | |
| Company Secretary & Compliance Officer | 2.1yrs | ₹4.50m | データなし | |
| Chief Operating Officer of Formulations | no data | ₹22.95m | データなし | |
| Vice President | no data | ₹12.40m | データなし | |
| Senior Vice President of Technical | no data | ₹6.06m | データなし | |
| Chief Human Resource Officer | no data | データなし | データなし | |
| Business Head of Biologics | no data | データなし | データなし | |
| Chief Scientific Officer of Biologicals | no data | ₹46.30m | データなし | |
| Head Operation of API | no data | データなし | データなし | |
| President of Global R&D | no data | データなし | データなし |
2.1yrs
平均在職期間
57yo
平均年齢
経験豊富な経営陣: SHILPAMEDの経営陣は 経験豊富 であると考えられます ( 2.1年の平均在職年数)。
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| MD & Director | 36.6yrs | ₹35.00m | 8.87% ₹ 4.4b | |
| VP of Projects & Operations and Whole-time Director | 4.7yrs | ₹14.50m | データなし | |
| Non-Executive Independent Director | 2.8yrs | ₹3.00m | データなし | |
| Non-Executive Independent Director | 1.9yrs | ₹2.25m | データなし | |
| Non-Executive Independent Director | 2.8yrs | ₹4.00m | データなし | |
| Non-Executive Chairman | 36.3yrs | ₹250.00k | 3.3% ₹ 1.6b | |
| Independent Women Director | 1.8yrs | ₹1.20m | データなし |
2.8yrs
平均在職期間
62yo
平均年齢
経験豊富なボード: SHILPAMEDの 取締役会 は 経験豊富 ではない ( 2.8年の平均在任期間) ため、新しい取締役会が必要であると考えられます。